Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 3153 (LINC03153) is a member of the lincRNA family, which are long non-coding RNAs transcribed from regions of the genome lying between protein-coding genes[1][7]. LincRNAs are typically >200 nucleotides and lack protein-coding capacity. These molecules commonly participate in gene regulatory networks, remodeling chromatin, modulating transcription, stabilizing other RNAs, and imparting cell-type-specific functions[1][7]. While many lincRNAs have been linked to disease processes, only a small fraction have been thoroughly characterized[1]. There is currently no specific structural, biological, or disease information, nor therapeutic relevance published for LINC03153. It remains an uncharacterized transcript in genome databases, with unknown disease associations, biological roles, and drug interactions.
None documented. No drug mechanisms are known for targeting this molecule.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 3153 (LINC03153).